Restricted accessResearch articleFirst published online 2016-09
Antistress Effects of Rosa rugosa Thunb. on Total Sleep Deprivation–Induced Anxiety-Like Behavior and Cognitive Dysfunction in Rat: Possible Mechanism of Action of 5-HT 6 Receptor Antagonist
Our previous results suggest that the Rosa rugosa Thunb. (family Rosaceae) alleviates endurance exercise-induced stress by decreasing oxidative stress levels. This study aimed to screen and identify the physiological antistress effects of an extract of R. rugosa (RO) on sleep deprivation–induced anxiety-like behavior and cognitive tests (in vivo) and tested for hippocampal CORT and monoamine levels (ex vivo), corticosterone (CORT)-induced injury, N-methyl-d-aspartate (NMDA) receptor, and serotonin 6 (5-hydroxytryptamine 6, 5-HT6) receptor activities (in vitro) in search of active principles and underlying mechanisms of action. We confirmed the antistress effects of RO in a sleep-deprived stress model in rat and explored the underlying mechanisms of its action. In conclusion, an R. rugosa extract showed efficacy and potential for use as an antistress therapy to treat sleep deprivation through its antagonism of the 5-HT6 receptor and resulting inhibition of cAMP activity.
Get full access to this article
View all access options for this article.
References
1.
MogilnickaE, BoissardCG, HunnC, Delini-StulaA: Suppressant effect of REM sleep deprivation on neophobia in normal rats and in rats with selective DSP-4 induced damage of locus coeruleus neurons. Pharmacol Biochem Behav, 1985; 23:93–97.
2.
HairstonIS, LittleMT, ScanlonMD, et al.: Sleep restriction suppresses neurogenesis induced by hippocampus-dependent learning. J Neurophysiol, 2005; 94:4224–4233.
3.
LucassenPJ, StumpelMW, WangQ, AronicaE: Decreased numbers of progenitor cells but no response to antidepressant drugs in the hippocampus of elderly depressed patients. Neuropharmacology, 2010; 58:940–949.
4.
CopinschiG: Metabolic and endocrine effects of sleep deprivation. Essent Psychopharmacol, 2005; 6:341–347.
5.
McEwenBS: Sleep deprivation as a neurobiologic and physiologic stressor: Allostasis and allostatic load. Metabolism, 2006; 55:S20–S23.
6.
KillgoreWD: Effects of sleep deprivation on cognition. Prog Brain Res, 2010; 185:105–129.
7.
WalkerMP, StickgoldR: Sleep-dependent learning and memory consolidation. Neuron, 2004; 44:121–133.
8.
ForestG, GodboutR: Effects of sleep deprivation on performance and EEG spectral analysis in young adults. Brain Cogn, 2000; 43:195–200.
9.
PeigneuxP, LaureysS, DelbeuckX, MaquetP: Sleeping brain, learning brain. The role of sleep for memory systems. Neuroreport, 2001; 12:A111–A124.
10.
YangRH, HouXH, XuXN, et al.: Sleep deprivation impairs spatial learning and modifies the hippocampal theta rhythm in rats. Neuroscience, 2011; 173:116–123.
ConradCD, GaleaLA, KurodaY, McEwenBS: Chronic stress impairs rat spatial memory on the Y maze, and this effect is blocked by tianeptine pretreatment. Behav Neurosci, 1996; 110:1321–1334.
13.
DugovicC, MaccariS, WeibelL, TurekFW, Van ReethO: High corticosterone levels in prenatally stressed rats predict persistent paradoxical sleep alterations. J Neurosci, 1999; 19:8656–8664.
14.
JacobBL, FornalCA: Serotonin and behaviour. A general hypothesis. In: Psychopharmacology: The Fourth Generation of Progress (BloomFE, KupferDJ, eds.) Raven Press Ltd., New York, 1995, pp. 461–469.
HoyerD, HannonJP, MartinGR: Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav, 2002; 71:533–554.
17.
GérardC, el MestikawyS, LebrandC, et al.: Quantitative RT-PCR distribution of serotonin 5-HT6 receptor mRNA in the central nervous system of control or 5,7-dihydroxytryptamine-treated rats. Synapse, 1996; 23:164–173.
18.
HirstWD, AbrahamsenB, BlaneyFE, et al.: Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling. Mol Pharmacol, 2003; 64:1295–1308.
19.
KinseyAM, WainwrightA, HeavensR, SirinathsinghjiDJ, OliverKR: Distribution of 5-ht(5A), 5-ht(5B), 5-ht(6) and 5-HT(7) receptor mRNAs in the rat brain. Brain Res Mol Brain Res, 2001; 88:194–198.
20.
RobertsJC, ReavillC, EastSZ, et al.: The distribution of 5-HT6 receptors in rat brain: An autoradiographic binding study using the radiolabelled 5-HT(6) receptor antagonist [125I]SB-258585. Brain Res, 2002; 934:49–57.
ZhangX, AndrenPE, GlennonRA, SvenningssonP: Distribution, level, pharmacology, regulation, and signaling of 5-HT6 receptors in rats and marmosets with special reference to an experimental model of parkinsonism. J Comp Neurol, 2011; 519:1816–1827.
23.
RuatM, TraiffortE, ArrangJM, et al.: A novel rat serotonin (5-HT6) receptor: Molecular cloning, localization and stimulation of cAMP accumulation. Biochem Biophys Res Commun, 1993; 193:268–276.
24.
HashidokoY: The phytochemistry of Rosa rugosa. Phytochemistry, 1996; 43:535–549.
25.
JungHJ, NamJH, ChoiJ, LeeKT, ParkHJ: 19Alpha-hydroxyursane-type triterpenoids: Antinociceptive anti-inflammatory principles of the roots of Rosa rugosa. Biol Pharm Bull, 2005; 28:101–104.
26.
YoshizawaY, KawaiiS, UrashimaM, et al.: Antiproliferative effects of small fruit juices on several cancer cell lines. Anticancer Res, 2000; 20:4285–4289.
27.
ParkJC, KimSC, ChoiMR, et al.: Anti-HIV protease activity from Rosa family plant extracts and rosamultin from Rosa rugosa. J Med Food, 2005; 8:107–109.
28.
NgTB, HeJS, NiuSM, et al.: A gallic acid derivative and polysaccharides with antioxidative activity from rose (Rosa rugosa) flowers. J Pharm Pharmacol, 2004; 56:537–545.
29.
WangB, DiaoQ, ZhangZ, et al.: Antitumor activity of bee pollen polysaccharides from Rosa rugosa. Mol Med Rep, 2013; 7:1555–1558.
30.
XieY, ZhangW: Antihypertensive activity of Rosa rugosa Thunb. flowers: Angiotensin I converting enzyme inhibitor. J Ethnopharmacol, 2012; 144:562–566.
31.
LeeYH, JungMG, KangHB, et al.: Effect of anti-histone acetyltransferase activity from Rosa rugosa Thunb. (Rosaceae) extracts on androgen receptor-mediated transcriptional regulation. J Ethnopharmacol, 2008; 118:412–417.
32.
AltinerD, KiliçgünH: The antioxidant effect of Rosa rugosa. Drug Metabol DrugInteract, 2008; 23:323–327.
33.
SeoE, YouY, YoonHG, et al.: Rosa rugosa aqueous extract alleviates endurance exercise-induced stress. J Med Food, 2015; 18:711–713.
34.
CohenHB, DementWC: Sleep: Changes in threshold to electroconvulsive shock in rats after deprivation of “paradoxical” phase. Science, 1965; 150:1318–1319.
35.
MorrisR: Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods, 1984; 11:47–60.
36.
BaeD, SeolH, YoonHG, et al.: Inhaled essential oil from Chamaecyparis obtuse ameliorates the impairments of cognitive function induced by injection of β-amyloid in rats. Pharm Biol, 2012; 50:900–910.
37.
MosmannT: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods, 1983; 65:55–63
38.
WoodMD, MurkittKL, RiceSQ, et al.: The human GABA(B1b) and GABA(B2) heterodimeric recombinant receptor shows low sensitivity to phaclofen and saclofen. Br J Pharmacol, 2000; 131:1050–1054.
39.
KimS, YunHM, BaikJH, ChungKC, NahSY, RhimH: Functional interaction of neuronal Cav1.3 L-type calcium channel with ryanodine receptor type 2 in the rat hippocampus. J Biol Chem, 2007; 282:32877–32889.
40.
YunHM, KimS, KimHJet al.: The novel cellular mechanism of human 5-HT6 receptor through an interaction with Fyn. J Biol Chem, 2007; 23:5496–5505.
41.
ZhengCF, GuanKL: Properties of MEKs, the kinases that phosphorylate and activate the extracellular signal-regulated kinases. J Biol Chem, 1993; 268:23933–23939.
42.
KopfSR., MelaniA, PedataF, PepeuG: Adenosine and memory storage: Effect of A(1) and A(2) receptor antagonists. Psychopharmacol, 1999; 146:214–219.
43.
Dall'IgnaOP, SouzaDO, LaraDR: Caffeine as a neuroprotective adenosine receptor antagonist. Ann Pharmacother, 2004; 38:717–718.
44.
LiebermanHR, WurtmanRJ, EmdeGG, CoviellaIL: The effects of caffeine and aspirin on mood and performance. J Clin Psychopharmacol, 1987; 7:315–320.
45.
AlhaiderIA, AleisaAM, TranTT, AlkadhiKA: Caffeine prevents sleep loss-induced deficits in long-term potentiation and related signaling molecules in the dentate gyrus. Eur J Neurosci, 2010; 31:1368–1376.
46.
GravesLA, HellerEA, PackAI, AbelT: Sleep deprivation selectively impairs memory consolidation for contextual fear conditioning. Learn Mem, 2003; 10:168–176.
47.
RothBL, HanizavarehSM, BlumAE: Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders. Psychopharmacology (Berl), 2004; 174:17–24.
48.
MitchellES, NeumaierJF: 5-HT6 receptors: A novel target for cognitive enhancement. Pharmacol Ther, 2005; 108:320–333.
49.
McGintyDJ, HarperRM: Dorsal raphe neurons: Depression of firing during sleep in cats. Brain Res, 1976; 101:569–575.
50.
PeñalvaRG, LancelM, FlachskammC, ReulJM, HolsboerF, LinthorstAC: Effect of sleep and sleep deprivation on serotonergic neurotransmission in the hippocampus: A combined in vivo microdialysis/EEG study in rats. Eur J Neurosci, 2003; 17:1896–1906.
51.
PortasCM, McCarleyRW: Behavioral state-related changes of extracellular serotonin concentration in the dorsal raphe nucleus: A microdialysis study in the freely moving cat. Brain Res, 1994; 648:306–312.
52.
TrulsonME, JacobsBL: Raphe unit activity in freely moving cats: Correlation with level of behavioral arousal. Brain Res, 1979; 163:135–150.
53.
MontiJM, JantosH: Effects of the 5-HT6 receptor antagonists SB-399885 and RO-4368554 and of the 5-HT(2A) receptor antagonist EMD 281014 on sleep and wakefulness in the rat during both phases of the light-dark cycle. Behav Brain Res, 2011; 216:381–388.
54.
LacroixLP, DawsonLA, HaganJJ, HeidbrederCA: 5-HT6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex. Synapse, 2004; 51:158–164.
55.
KingMV, MarsdenCA, FoneKC: A role for the 5-HT1A, 5-HT4 and 5-HT6 receptors in learning and memory. Trends Pharmacol Sci, 2008; 29:482–492.
56.
NorumJH, HartK, LevyFO: Ras-dependent ERK activation by the human G(s)-coupled serotonin receptors 5-HT4(b) and 5-HT7(a).J Biol Chem, 2003; 278:3098–3104.
